Cigarette smoking, appendectomy and tonsillectomy as risk factors for the development of primary sclerosing cholangitis (PSC): A case control study.

Cigarette smoking, appendectomy and tonsillectomy as risk factors for the development of primary sclerosing cholangitis (PSC): A case control study.

書誌詳細
主要な著者:	Mitchell, SA, Thyssen, M, Mitchell, M, Orchard, T, Jewell, D, Fleming, K, Chapman, R
フォーマット:	Journal article
出版事項:	1998

類似資料

Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study.
著者:: Mitchell, SA, 等
出版事項: (2002)

Cytokine profiles in primary sclerosing cholangitis (PSC) and autoimmune liver diseases: Comparing expression in the periphery and the liver.
著者:: Mitchell, SA, 等
出版事項: (1997)

Primary sclerosing cholangitis.
著者:: Mitchell, SA, 等
出版事項: (2000)

Enhanced cytokine mRNA expression in Primary Sclerosing Cholangitis (PSC) and autoimmune liver diseases.
著者:: Mitchell, S, 等
出版事項: (1997)

ADHESION MOLECULE EXPRESSION IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
著者:: Bloom, S, 等
出版事項: (1992)

The management of primary sclerosing cholangitis.
著者:: Mitchell, SA, 等
出版事項: (1998)

TISSUE DISTRIBUTION OF AN AUTOANTIGEN SPECIFIC FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
著者:: Lo, S, 等
出版事項: (1992)

Deposition of complement C9 in primary sclerosing cholangitis (PSC).
著者:: Shanahan, J, 等
出版事項: (1998)

IMMUNOGENETIC FACTORS IN THE CLINICAL COURSE OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
著者:: Mehal, W, 等
出版事項: (1993)

Down regulation of interferon gamma and up regulation of interleukin-10 by ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC).
著者:: Mitchell, SA, 等
出版事項: (1997)

Role of interleukin-10 in the pathogenesis of primary sclerosing cholangitis and primary biliary cirrhosis?
著者:: Mitchell, SA, 等
出版事項: (1998)

Review article: the management of primary sclerosing cholangitis.
著者:: Mitchell, SA, 等
出版事項: (1997)

New time dependent prognostic models for primary sclerosing cholangitis (PSC)
著者:: Rocca, G, 等
出版事項: (2000)

INAPPROPRIATE EXPRESSION OF BLOOD-GROUP ANTIGENS ON THE BILIARY EPITHELIUM IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
著者:: Bloom, S, 等
出版事項: (1990)

Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
著者:: Chapman, R
出版事項: (2010)

Primary sclerosing cholangitis--an immunologically mediated disease?
著者:: Chapman, R, 等
出版事項: (1985)

Liver cell proliferation in primary sclerosing cholangitis (PSC), as assessed by anti-KI-67 labelling.
著者:: Shanahan, J, 等
出版事項: (1998)

PORTAL TRACT LYMPHOCYTE POPULATIONS IN PRIMARY SCLEROSING CHOLANGITIS
著者:: Snook, J, 等
出版事項: (1987)

ANTINEUTROPHIL ANTIBODY AND PRIMARY SCLEROSING CHOLANGITIS
著者:: Lo, S, 等
出版事項: (1991)

Primary sclerosing cholangitis
著者:: Chapman, R
出版事項: (2007)

Primary sclerosing cholangitis.
著者:: Chapman, R
出版事項: (1985)

High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.
著者:: Mitchell, SA, 等
出版事項: (1997)

Primary sclerosing cholangitis.
著者:: Cullen, S, 等
出版事項: (2003)

A regulatory polymorphism of the stromelysin gene (MMP-3) strongly influences susceptibility to primary sclerosing cholangitis (PSC) and progression to portal hypertension.
著者:: Satsangi, J, 等
出版事項: (2000)

Primary sclerosing cholangitis.
著者:: Williamson, K, 等
出版事項: (2014)

Primary sclerosing cholangitis.
著者:: Worthington, J, 等
出版事項: (2006)

Primary sclerosing cholangitis
著者:: Chapman Roger, 等
出版事項: (2006-10-01)

Decreased interleukin-10 mRNA expression in primary sclerosing cholangitis and primary biliary cirrhosis: A role for IL10 in the pathogenesis?
著者:: Mitchell, SA, 等
出版事項: (1997)

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.
著者:: Mitchell, SA, 等
出版事項: (2001)

Characterization of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis (PSC) ulcerative colitis (UC).
著者:: Cameron, B, 等
出版事項: (1998)

OLIGONUCLEOTIDE DNA TYPING ANALYSIS OF THE HLA DRB3 LOCUS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC)
著者:: Mehal, W, 等
出版事項: (1991)

INTERFERON-GAMMA PRODUCTION IN PRIMARY SCLEROSING CHOLANGITIS
著者:: Martins, E, 等
出版事項: (1995)

ANTI-NEUTROPHIL NUCLEAR ANTIBODY IN INFLAMMATORY BOWEL-DISEASE AND PRIMARY SCLEROSING CHOLANGITIS
著者:: Snook, J, 等
出版事項: (1988)

Is the 308 polymorphism in the tumor necrosis factor (alpha) (TNF alpha) promoter region a marker of disease susceptibility in European patients with primary sclerosing cholangitis (PSC)?
著者:: Mitchell, SA, 等
出版事項: (1998)

The management of primary sclerosing cholangitis.
著者:: Chapman, R
出版事項: (2003)

The immunology of primary sclerosing cholangitis.
著者:: Chapman, R
出版事項: (1990)

Primary sclerosing cholangitis - Foreword
著者:: Chapman, R
出版事項: (2006)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
著者:: Chapman, R
出版事項: (1993)

High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomised double-blind, placebo-controlled trial.
著者:: Mitchell, S, 等
出版事項: (1997)

Tissue distribution of autoantigen specific for primary sclerosing cholangitis.
著者:: Lo, S, 等
出版事項: (1993)